Effectiveness of Erector Spinae Plane Block for Percutaneous Arthrodesis of Spinal Fractures: a Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Spinal fracture surgery is a common surgery. Post-operative pain has been reduced by the advent of so-called minimally invasive techniques. The immediate post-operative pain, however, remains relatively high, mainly because of muscle pain following the trauma. The erector spinae plane block (ESPB) is a loco-regional anesthesia technique first described in 2016. A retrospective cohort study showed an improvement in post-operative analgesia of percutaneous osteosynthesis spinal surgery through a reduction in 24-hour morphine use. In order to prove and confirm the effectiveness of this technique, we will conduct a double-blind randomized controlled study. The objective will be to demonstrate the analgesic effectiveness of the technique by reducing morphine consumption in post-operative. The expected reduction in morphine consumption is set at 30%, based on the clinical experience developed in our practice.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with percutaneous arthrodesis spine surgery for fracture

• Insured persons

• Age 18 years

• Being able to receive informed information

• Have agreed to participate in writing

Locations
Other Locations
France
Hôpital Roger Salengro
RECRUITING
Lille
Contact Information
Primary
Cédric CIRENEI, MD
cedric.cirenei@chru-lille.fr
0320445962
Time Frame
Start Date: 2024-04-11
Estimated Completion Date: 2026-07
Participants
Target number of participants: 86
Treatments
Experimental: Erector spinae plane block with naropeine [3,75 mg/mL]
Experimental group: Erector spinae plane block with naropeine \[3,75 mg/mL\]
Active_comparator: Control group : ESPB with saline 0,9%
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Lille

This content was sourced from clinicaltrials.gov